A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

NCT01201902 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

592

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Infection

Interventions

BIOLOGICAL: Adjuvanted influenza A(H1N1) vaccine
BIOLOGICAL: Adjuvanted influenza A(H1N1) vaccine
BIOLOGICAL: un-adjuvanted influenza A(H1N1) vaccine
BIOLOGICAL: Adjuvanted influenza A(H1N1) vaccine
BIOLOGICAL: Adjuvanted influenza A(H1N1) vaccine

Sponsor

Green Cross Corporation